Suppr超能文献

使用阿替利珠单抗联合贝伐珠单抗治疗合并微卫星稳定的直肠癌伴门静脉癌栓和肺转移的肝细胞癌。

Treatment of hepatocellular carcinoma with a portal vein tumor thrombus and pulmonary metastases of rectal cancer with microsatellite stability using atezolizumab plus bevacizumab.

机构信息

Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Department of Radiology, Shiga University of Medical Science, Otsu, Shiga, Japan.

出版信息

Clin J Gastroenterol. 2024 Apr;17(2):286-291. doi: 10.1007/s12328-024-01921-2. Epub 2024 Feb 11.

Abstract

Herein, we report the successful treatment using atezolizumab plus bevacizumab of a patient with hepatocellular carcinoma (HCC) with a portal vein tumor thrombus and multiple pulmonary metastases from rectal cancer with microsatellite stability. This patient developed rectal cancer with synchronous pulmonary metastases and HCC. After resecting the primary lesion of the rectal cancer, transcatheter arterial chemoembolization was performed for the HCC. Drug therapy was planned for multiple pulmonary metastases of rectal cancer; however, the early development of recurrent HCC with portal vein tumor thrombus had to be highly prioritized, and atezolizumab plus bevacizumab was introduced. Following the disappearance of the recurrent HCC lesion, the metastatic pulmonary nodules shrunk into scar-like spots. The treatment for both HCC and pulmonary metastases of rectal cancer were considered to result in clinical complete response.

摘要

在此,我们报告了一例成功的治疗案例,一名结直肠癌合并微卫星稳定的肝细胞癌(HCC)患者,其存在门静脉癌栓和多发肺转移。该患者同时患有直肠癌合并肺转移和 HCC。在切除直肠癌的原发灶后,对 HCC 进行了经导管动脉化疗栓塞。直肠癌的多发肺转移计划进行药物治疗,但 HCC 伴门静脉癌栓的早期复发需要高度优先处理,因此引入了阿替利珠单抗联合贝伐珠单抗。在复发性 HCC 病变消失后,转移性肺结节缩小成瘢痕样斑点。HCC 和结直肠癌的肺转移治疗均被认为达到了临床完全缓解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验